Clinical trial
Phase I/II Study of the Effects of Antibiotics on Sarcoidosis Pathogenesis
NCT01074554 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I/II Study of the Effects of Antibiotics on Sarcoidosis Pathogenesis
- Lead sponsor
- Vanderbilt University
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- February 28, 2011
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.